Eglumegad (LY354740) hydrochloride is a potent, selective agonist for group II (mGlu2/3) receptors, exhibiting IC50 values of 5 nM for mGlu2 and 24 nM for mGlu3 receptors when transfected into human cells. This compound confers neuroprotection against NMDA-induced toxicity and has demonstrated anxiolytic- and antipsychotic-like properties [1].